Skip to main content

Table 3 Relation between combined neuropathy score with different parameters (n = 81)

From: The relationship between vascular endothelial growth factor-A serum level and the severity of diabetic peripheral neuropathy

 

Combined categories

Test of sig.

P

No neuropathy

Subclinical neuropathy

Confirmed neuropathy

No.

%

No.

%

No.

%

Duration of DM (years)

 Median

2.0

7.50

10.0

H= 16.537*

< 0.001*

 Min.–max.

0.08–20.0

1.0–25.0

1.0–40.0

 Mean ± SD

3.84 ± 5.47

8.27 ± 6.03

11.66 ± 7.76

Sig. between categories

P1= 0.010*,P2< 0.001*,P3 = 0.073

  

BMI (kg/m2)

 Median

28.70

28.95

31.95

F = 0.425

0.655

 Min.–max.

18.30–36.0

20.30–47.60

17.40–40.30

 Mean ± SD

28.75 ± 4.74

30.15 ± 5.89

30.43 ± 5.81

HbA1c

 Median

7.50

8.0

9.55

F= 15.507*

< 0.001*

 Min.–max

6.90–7.90

6.30–11.40

5.40–13.90

 Mean ± SD

7.43 ± 0.34

8.03 ± 1.24

9.75 ± 1.98

Sig. between categories

P1 = 0.489, P2< 0.001*,P3< 0.001*

  

Total cholesterol

 Median

185.0

206.50

220.0

F= 4.210*

0.018*

 Min.–max.

141.0–224.0

130.0–252.0

132.0–272.0

 Mean ± SD.

185.54 ± 23.80

199.97 ± 27.09

212.63 ± 34.33

Sig. between categories

P1 = 0.329, P2= 0.018*,P3 = 0.208

  
  1. F F for ANOVA test, pairwise comparison bet. Each 2 groups was done using post hoc test (Tukey). H H for Kruskal-Wallis test, pairwise comparison bet. Each 2 groups was done using post hoc test (Dunn’s multiple comparisons test. P p-value for comparing between the different categories. P1p-value for comparing between patients without DPN and patients with subclinical DPN. P2p-value for comparing between patients without DPN and patients with confirmed DPN. P3p-value for comparing between patients with subclinical DPN and patients with confirmed DPN
  2. No. Number, % Percentage, DM Diabetes mellitus, BMI Body mass index, HbA1c Glycosylated hemoglobin, SD Standard deviation, sig. Significance, min Minimum, max Maximum
  3. *Statistically significant at P ≤ 0.05